211 related articles for article (PubMed ID: 24874458)
1. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
[TBL] [Abstract][Full Text] [Related]
2. CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis.
Wurbel MA; McIntire MG; Dwyer P; Fiebiger E
PLoS One; 2011 Jan; 6(1):e16442. PubMed ID: 21283540
[TBL] [Abstract][Full Text] [Related]
3. Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.
Apostolaki M; Manoloukos M; Roulis M; Wurbel MA; Müller W; Papadakis KA; Kontoyiannis DL; Malissen B; Kollias G
Gastroenterology; 2008 Jun; 134(7):2025-35. PubMed ID: 18439426
[TBL] [Abstract][Full Text] [Related]
4. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice.
Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R
PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795
[TBL] [Abstract][Full Text] [Related]
5. MLN3126, an antagonist of the chemokine receptor CCR9, ameliorates inflammation in a T cell mediated mouse colitis model.
Igaki K; Komoike Y; Nakamura Y; Watanabe T; Yamasaki M; Fleming P; Yang L; Soler D; Fedyk E; Tsuchimori N
Int Immunopharmacol; 2018 Jul; 60():160-169. PubMed ID: 29730559
[TBL] [Abstract][Full Text] [Related]
6. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.
Trivedi PJ; Bruns T; Ward S; Mai M; Schmidt C; Hirschfield GM; Weston CJ; Adams DH
J Autoimmun; 2016 Apr; 68():98-104. PubMed ID: 26873648
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice.
Samson CM; Jurickova I; Molden E; Schreiner W; Colliver J; Bonkowski E; Han X; Trapnell BC; Denson LA
Inflamm Bowel Dis; 2011 Dec; 17(12):2443-55. PubMed ID: 21381154
[TBL] [Abstract][Full Text] [Related]
8. CCR9 Antagonists in the Treatment of Ulcerative Colitis.
Bekker P; Ebsworth K; Walters MJ; Berahovich RD; Ertl LS; Charvat TT; Punna S; Powers JP; Campbell JJ; Sullivan TJ; Jaen JC; Schall TJ
Mediators Inflamm; 2015; 2015():628340. PubMed ID: 26457007
[TBL] [Abstract][Full Text] [Related]
9. The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice.
Wermers JD; McNamee EN; Wurbel MA; Jedlicka P; Rivera-Nieves J
Gastroenterology; 2011 May; 140(5):1526-35.e3. PubMed ID: 21300065
[TBL] [Abstract][Full Text] [Related]
10. CCR9+ plasmacytoid dendritic cells in the small intestine suppress development of intestinal inflammation in mice.
Mizuno S; Kanai T; Mikami Y; Sujino T; Ono Y; Hayashi A; Handa T; Matsumoto A; Nakamoto N; Matsuoka K; Hisamatsu T; Takaishi H; Hibi T
Immunol Lett; 2012 Aug; 146(1-2):64-9. PubMed ID: 22626536
[TBL] [Abstract][Full Text] [Related]
11. C-C motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice.
Amiya T; Nakamoto N; Irie J; Taniki N; Chu PS; Koda Y; Miyamoto K; Yamaguchi A; Shiba S; Morikawa R; Itoh H; Kanai T
Diabetologia; 2021 Mar; 64(3):603-617. PubMed ID: 33399911
[TBL] [Abstract][Full Text] [Related]
12. Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria.
Wurbel MA; Malissen M; Guy-Grand D; Malissen B; Campbell JJ
J Immunol; 2007 Jun; 178(12):7598-606. PubMed ID: 17548595
[TBL] [Abstract][Full Text] [Related]
13. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
[TBL] [Abstract][Full Text] [Related]
14. Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.
Rivera-Nieves J; Ho J; Bamias G; Ivashkina N; Ley K; Oppermann M; Cominelli F
Gastroenterology; 2006 Nov; 131(5):1518-29. PubMed ID: 17101325
[TBL] [Abstract][Full Text] [Related]
15. CCR9 and CCL25: A review of their roles in tumor promotion.
Xu B; Deng C; Wu X; Ji T; Zhao L; Han Y; Yang W; Qi Y; Wang Z; Yang Z; Yang Y
J Cell Physiol; 2020 Dec; 235(12):9121-9132. PubMed ID: 32401349
[TBL] [Abstract][Full Text] [Related]
16. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
[TBL] [Abstract][Full Text] [Related]
17. Impaired CCR9/CCL25 signalling induced by inefficient dendritic cells contributes to intestinal immune imbalance in nonalcoholic steatohepatitis.
Gao W; Wang Y; Bi J; Chen X; Li N; Wang Y; Tang H; Mao J
Biochem Biophys Res Commun; 2021 Jan; 534():34-40. PubMed ID: 33310185
[TBL] [Abstract][Full Text] [Related]
18. Expression and histopathological correlation of CCR9 and CCL25 in ovarian cancer.
Singh R; Stockard CR; Grizzle WE; Lillard JW; Singh S
Int J Oncol; 2011 Aug; 39(2):373-81. PubMed ID: 21637913
[TBL] [Abstract][Full Text] [Related]
19. CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes.
Ericsson A; Svensson M; Arya A; Agace WW
Eur J Immunol; 2004 Oct; 34(10):2720-9. PubMed ID: 15368288
[TBL] [Abstract][Full Text] [Related]
20. CCR9 signaling in dendritic cells drives the differentiation of Foxp3
Pathak M; Padghan P; Halder N; Shilpi ; Kulkarni N; Sonar SA; Lal G
Eur J Immunol; 2020 Mar; 50(3):404-417. PubMed ID: 31755547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
